Merck
CN
Search Within
文件类型

579-60-2

应用筛选条件
关键词:'579-60-2'
显示 1-30 共 87 条结果 关于 "579-60-2" 范围 技术文档
Data Sheet - G5163
KDIDFLIEEIER- LGQDL corresponding to the C-terminal region of GAD 67 of human origin (amino acids 579-594 with N-terminally added lysine) as immunogen. This sequence is identical in human GAD 65 (amino
Quality Control Range Sheet- HSTC-108 and HSTC-208
Control 2 684 – 1422 pg/mL Control 2 176 – 366 pg/mL IFNγ Control 1 16 – 32 pg/mL IL-12 (p70) Control 1 67 – 138
Data Sheet - F7134
biosensors. Biosens. Bioelectron., 14(6), 579-585 (1999). 5. Riboni, L., et al., A fast staining method for CNS slices. J. Neurosci. Methods, 38(2-3), 239-241 (1991). 6. Matsui, S., et al
Product Information Sheet - F2877
biosensors. Biosens. Bioelectron., 14(6), 579-585 (1999). 5. Riboni, L., et al., A fast staining method for CNS slices. J. Neurosci. Methods, 38(2-3), 239-241 (1991). 6. Matsui, S., et al
Data Sheet - 52291
Description MW 699 g/mol εmax 1.1 x 10 5 M -1 cm -1
Data Sheet - P1613
DNA-protein interactions. The regulation of poly(ADP-ribose) polymerase. Eur. J. Biochem., 127, 579-85 (1982). 2. Giner, H., et al., Overproduction and large-scale purification of the human poly(ADP-ribose
Data Sheet - 51490
578 (1968) 2. S. King, W.I. Metzger, A new plating medium for the isolation of enteric pathogens. II. Comparison of Hektoen Enteric Agar with SS and EMB Agar, Appl. Microbiol. 16, 579-581(1968)
Data Sheet - C8206
Nattel, S. and Singh, B.N., Am. J. Cardiol., 84, 11R (1999). 13. Singh, V. et al., Drugs, 58, 579 (1999). 14. Rodnitzky, R.L., Drugs, 57, 845 (1999) MCT,PHC 11/05-1
Anti-Calcium Channel (alpha1A Subunit) (P/Q-Type of Voltage-Gated Ca2+ Channel) (C1353)
Nattel, S. and Singh, B. N., Am. J. Cardiol., 84, 11R (1999). 14. Singh, V. et al., Drugs, 58, 579 (1999). 15. Rodnitzky, R. L., Drugs, 57, 845 (1999). 16. Westenbroek, R. E., et al., J.
Anti-Calcium Channel (Cardiac alpha1C Subunit) (L-type of Voltage-gated Ca2+ Channel) (C4980)
Nattel, S. and Singh, B.N., Am. J. Cardiol., 84, 11R (1999). 13. Singh, V. et al., Drugs, 58, 579 (1999). 14. Rodnitzky, R.L., Drugs, 57, 845 (1999). 15. Shistik, E. et al., J. Biol. Chem., 274, 31145
Anti-Calcium Channel (b3 Subunit) (Cacnb3l) antibody produced in rabbit (C1978)
Nattel, S. and Singh, B.N., Am. J. Cardiol., 84, 11R (1999). 13. Singh, V. et al., Drugs, 58, 579 (1999). 14. Rodnitzky, R.L., Drugs, 57, 845 (1999). lpg 3/00
Developed in Rabbit Affinity Isolated AntibodyAnti-cdk-1 (p34cdc2)
Nattel, S., and Singh, B.N., Am. J. Cardiol., 84, 11R (1999). 13. Singh, V., et al., Drugs, 58, 579 (1999). 14. Rodnitzky, R.L., Drugs, 57, 845 (1999). MJE,BR,PHC 08/10-1 Sigma brand products are
Anti-Calcium Channel ( 1B Subunit)
Nattel, S. and Singh, B.N., Am. J. Cardiol., 84, 11R (1999). 12. Singh, V. et al., Drugs, 58, 579 (1999). 13. Rodnitzky, R. L., Drugs, 57, 845 (1999). 14. Westenbroek, R. E., et al., J.
ANTI-CALCIUM CHANNEL (a1E Subunit)
Nattel, S. and Singh, B.N., Am. J. Cardiol., 84, 11R (1999). 15. Singh, V. et al., Drugs, 58, 579 (1999). 16. Rodnitzky, R.L., Drugs, 57, 845 (1999). 17. Westenbroek, R.E.
Anti-Calcium Channel (alpha1 Subunit) Pan (C1103)
Nattel, S. and Singh, B.N., Am. J. Cardiol., 84, 11R (1999). 16. Singh, V. et al., Drugs, 58, 579 (1999). 17. Rodnitzky, R. L., Drugs, 57, 845 (1999). 18. Westenbroek, R.E., et al., J. Neurosci
Anti-Calcium Channel (a1D Subunit) (L-type of Voltage-gated Ca2+ Channel) antibody produced in rabbit (C1728)
Committee for the Prevention, Detection, Evaluation and Treatment of High Blood Pressure., Drugs, 58, 579 (1999). 15. Rodnitzky, R.L., Can calcium antagonists provide a neuroprotective effect in Parkinson's
Data Sheet - P7114
using a synthetic phosphorylated peptide derived from the region of human Pyk2 that contains tyrosine 579 as immunogen. The antiserum is affinity purified using epitope-specific affinity chromatography.
Anti-Calcium Channel (a1C Subunit) (L-type of Voltage-gated Ca2+ Channel) antibody produced in rabbit (C1603)
Committee for the Prevention, Detection, Evaluation and Treatment of High Blood Pressure., Drugs, 58, 579-87 (1999). 16. Rodnitzky, R.L., Can calcium antagonists provide a neuroprotective effect in Parkinson's
XP725 Antibody Number-Lot Number 071M4826
c-d e-f g-h a-b c-d e-f g-h 1.1 1 2 3 4 25 26 27 28 49 50 51 52 73 74 75 76 1.2 5 6 7 8 29 30 31 32 53 54 55 56 77 78 79
Milli-Q® Reference Water Purification System
supply frequency 50 – 60 Hz ± 10% Feed water connection 1/2 in. Gaz F Data connection Ethernet (RJ45) Q-POD® accessory dimensions Parameter Value & Unit Q-POD® height 579 mm (23.50 in.) Q-POD
Product Information Sheet - SE120041
., The appearance of acute phase protein in various diseases. Acta Med. Scand., 128(Suppl. 196), 579-601 (1947). 9. Morley, J.J., and Kushner, I., Serum C-reactive Protein Levels. in C-Reactive Protein
Product Information - CSAA1
Pyk2 P3902 Signal Transduction P y y y 219 Pyk2 Phospho (pY 579) P7114 Signal Transduction P y n/d y 220 Pyk2 Phospho (pY 579/580) P6989 Signal Transduction P y n/d n/d 221 Pyk2
Product Information Sheet - MTOX1000P24
618 565 539 494 497 607 579 528 390 561 580 534 475 427 511 434 671 3 Transwell Assay This protocol is designed to assess drug transporter functionality in Caco-2 cells. The experiment
Product Information Sheet - MTOX1000CC24
618 565 539 494 497 607 579 528 390 561 580 534 475 427 511 434 671 Transwell Assay: This protocol is designed to assess drug transporter functionality in Caco-2 cells. Transport is measured
Product Information Sheet - MTOX1001P24
507 610 618 565 539 494 497 607 579 528 390 561 580 534 475 427 511 434 671 Transwell Assay This protocol is designed to assess drug transporter functionality in Caco-2 cells. The experiment must include
Product Information Sheet - MTOX1002P24
507 610 618 565 539 494 497 607 579 528 390 561 580 534 475 427 511 434 671 Transwell Assay This protocol is designed to assess drug transporter functionality in Caco-2 cells. The experiment must include
Product Information Sheet - MTOX1005P24
507 610 618 565 539 494 497 607 579 528 390 561 580 534 475 427 511 434 671 Transwell Assay This protocol is designed to assess drug transporter functionality in Caco-2 cells. The experiment must include
Product Information Sheet - MTOX1004P24
507 610 618 565 539 494 497 607 579 528 390 561 580 534 475 427 511 434 671 Transwell Assay This protocol is designed to assess drug transporter functionality in Caco-2 cells. The experiment must include
Product Information Sheet - MTOX1006P24
507 610 618 565 539 494 497 607 579 528 390 561 580 534 475 427 511 434 671 Transwell Assay This protocol is designed to assess drug transporter functionality in Caco-2 cells. The experiment must include
Product Information Sheet - MTOX1003P24
507 610 618 565 539 494 497 607 579 528 390 561 580 534 475 427 511 434 671 Transwell Assay This protocol is designed to assess drug transporter functionality in Caco-2 cells. The experiment must include
1/3